ROFLUMILAST for Dermatitis atopic: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 26 adverse event reports in the FDA FAERS database where ROFLUMILAST was used for Dermatitis atopic.
Most Reported Side Effects for ROFLUMILAST
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 569 | 21.1% | 568 | 8 |
| Dyspnoea | 433 | 16.0% | 7 | 191 |
| Chronic obstructive pulmonary disease | 292 | 10.8% | 26 | 158 |
| Diarrhoea | 265 | 9.8% | 6 | 82 |
| Off label use | 242 | 9.0% | 7 | 65 |
| Weight decreased | 224 | 8.3% | 8 | 74 |
| Nausea | 191 | 7.1% | 5 | 36 |
| Pneumonia | 176 | 6.5% | 7 | 123 |
| Headache | 166 | 6.2% | 2 | 26 |
| Malaise | 164 | 6.1% | 6 | 48 |
| Asthma | 158 | 5.9% | 0 | 76 |
| Drug ineffective | 156 | 5.8% | 1 | 30 |
| Decreased appetite | 151 | 5.6% | 6 | 44 |
| Insomnia | 151 | 5.6% | 2 | 29 |
| Cough | 140 | 5.2% | 0 | 40 |
Other Indications for ROFLUMILAST
Chronic obstructive pulmonary disease (945)
Product used for unknown indication (369)
Psoriasis (149)
Seborrhoeic dermatitis (61)
Emphysema (40)
Asthma (27)
Pseudomonas infection (27)
Dyspnoea (22)
Eczema (15)
Bronchitis chronic (14)
Other Drugs Used for Dermatitis atopic
DUPILUMAB (179,563)
UPADACITINIB (5,263)
TRALOKINUMAB-LDRM (3,007)
CRISABOROLE (2,139)
ABROCITINIB (1,616)
NEMOLIZUMAB-ILTO (1,596)
RUXOLITINIB (740)
TACROLIMUS (515)
METHOTREXATE (400)
CYCLOSPORINE (370)